Influence of reversal of neuromuscular blockade with sugammadex or neostigmine on postoperative quality of recovery following a single bolus dose of rocuronium: A prospective, randomized, double-blinded, controlled study.

[1]  A. Afshari,et al.  The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta‐analysis and trial sequential analysis , 2018, Anaesthesia.

[2]  M. Paech,et al.  Recovery characteristics of patients receiving either sugammadex or neostigmine and glycopyrrolate for reversal of neuromuscular block: a randomised controlled trial , 2018, Anaesthesia.

[3]  G. Kostopanagiotou,et al.  Effect of Sugammadex versus Neostigmine/Atropine Combination on Postoperative Cognitive Dysfunction after Elective Surgery , 2017, Anaesthesia and intensive care.

[4]  C. R. Bailey.  Sugammadex: when should we be giving it? , 2017, Anaesthesia.

[5]  Hyun Kang,et al.  Effects of sugammadex vs. pyridostigmine–glycopyrrolate on post‐operative nausea and vomiting: propensity score matching , 2017, Acta anaesthesiologica Scandinavica.

[6]  V. Hancı,et al.  [Comparison of the effects of sugammadex and neostigmine on postoperative nausea and vomiting]. , 2017, Revista brasileira de anestesiologia.

[7]  A. Fassoulaki,et al.  Sugammadex at both high and low doses does not affect the depth of anesthesia or hemodynamics: a randomized double blind trial , 2017, Journal of Clinical Monitoring and Computing.

[8]  J. Jakobsson,et al.  Evaluation of the Postoperative Quality of Recovery Scale test and re-test in Swedish among healthy volunteers , 2016, F1000Research.

[9]  D. Kızılay,et al.  Comparison of neostigmine and sugammadex for hemodynamic parameters in cardiac patients undergoing noncardiac surgery. , 2016, Journal of clinical anesthesia.

[10]  I. Lee,et al.  Sugammadex facilitates early recovery after surgery even in the absence of neuromuscular monitoring in patients undergoing laryngeal microsurgery: a single-center retrospective study , 2015, BMC Anesthesiology.

[11]  D. Sessler,et al.  Comparison of sugammadex and conventional reversal on postoperative nausea and vomiting: a randomized, blinded trial. , 2015, Journal of clinical anesthesia.

[12]  N. Okamoto,et al.  Feasibility, reliability, and validity of the Japanese version of the Postoperative Quality of Recovery Scale: a first pilot study , 2015, Journal of Anesthesia.

[13]  P. Leão,et al.  Sugammadex Reduces Postoperative Pain After Laparoscopic Bariatric Surgery: A Randomized Trial , 2014, Surgical laparoscopy, endoscopy & percutaneous techniques.

[14]  P. Amorim,et al.  Neostigmine vs. sugammadex: observational cohort study comparing the quality of recovery using the Postoperative Quality Recovery Scale , 2014, Acta anaesthesiologica Scandinavica.

[15]  L. Sahin,et al.  Does Rocuronium-Sugammadex Reduce Myalgia and Headache After Electroconvulsive Therapy in Patients With Major Depression? , 2014, The journal of ECT.

[16]  P. Beaulé,et al.  Validity of a short-term quality of life questionnaire in patients undergoing joint replacement: the Quality of Recovery-40. , 2012, The Journal of arthroplasty.

[17]  I. Glurich,et al.  Consensus guideline adoption for managing postoperative nausea and vomiting. , 2012, WMJ : official publication of the State Medical Society of Wisconsin.

[18]  M. Fischler,et al.  Sugammadex administration results in arousal from intravenous anaesthesia: a clinical and electroencephalographic observation. , 2011, British journal of anaesthesia.

[19]  K. Olkkola,et al.  Reversal of neuromuscular blockade by sugammadex does not affect EEG derived indices of depth of anesthesia , 2010, Journal of Clinical Monitoring and Computing.

[20]  J. Bellemans,et al.  Key interventions and outcomes in joint arthroplasty clinical pathways: a systematic review. , 2010, Journal of evaluation in clinical practice.

[21]  K. A. Cullen,et al.  Ambulatory surgery in the United States, 2006. , 2009, National health statistics reports.

[22]  S. Brull,et al.  Sugammadex: a novel selective relaxant binding agent , 2009, Expert review of clinical pharmacology.

[23]  F. Donati.  Sugammadex: a cyclodextrin to reverse neuromuscular blockade in anaesthesia , 2008, Expert opinion on pharmacotherapy.

[24]  D. Sessler,et al.  Does Neostigmine Administration Produce a Clinically Important Increase in Postoperative Nausea and Vomiting? , 2005, Anesthesia and analgesia.

[25]  M. Schywalsky,et al.  [A comparison of the two anticholinergic agents atropine and glycopyrrolate during antagonism of a muscle relaxation with pyridostigmine]. , 1993, Anaesthesiologie und Reanimation.

[26]  D. Grob,et al.  Adverse Cardiovascular Effects of Anticholinesterase Medications , 1987, The American journal of the medical sciences.

[27]  J. Dundee,et al.  Comparison of atropine and glycopyrrolate in a mixture with pyridostigmine for the antagonism of neuromuscular block. , 1981, British journal of anaesthesia.